Sofía Mira Martínez

Dr. Sofía Mira Martínez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2024 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
RCRocío Zamanillo Campos
Rocío Zamanillo Campos
MFMaria A Fiol-deRoque
Maria A Fiol-deRoque
MSMARIA J SERRANO-RIPOLL
MARIA J SERRANO-RIPOLL
JLJoan Llobera-Canaves
Joan Llobera-Canaves
JTJoana María Taltavull-Aparicio
Joana María Taltavull-Aparicio
IRIgnacio Ricci-Cabello
Ignacio Ricci-Cabello
Background: Complications arising from uncontrolled type 2 diabetes mellitus (T2DM) pose a significant burden on individuals’ wellbeing and healthcare resources. Digital interventions may play a key role in mitigating such complications by supporting patients to adequately self-manage their condition. Aim: To assess the impact of DiabeText, a new theory-based, patient-centred, mobile health intervention integrated with electronic health records to send tailored short text messages to support T2DM self-management. Design and setting: A pragmatic, phase-three, 12-month, two-arm randomised clinical trial involving primary care patients with T2DM in the Balearic Islands, Spain, including in urban and rural areas. Method: In total, 742 participants with suboptimal glycaemic control (glycated haemoglobin [HbA1c] level >7.5) were randomly allocated to a control (usual care) or intervention (DiabeText) group. In addition to usual care, the DiabeText group received 167 messages focused on healthy lifestyle and medication adherence. The primary outcome was HbA1c level. Secondary outcomes were: medication possession ratio; health-related quality of life (measured using the EQ-5D-5L questionnaire); diabetes self-efficacy (measured using the Diabetes Self-Efficacy Scale [DSES]); and self-reported adherence to medication, Mediterranean diet (measured using the 14-Item Mediterranean Diet Adherence Screener [MEDAS-14]), and physical activity (measured using the International Physical Activity Questionnaire [IPAQ]). Results: Over the 12-month period, no statistically significant differences in HbA1c were observed between the intervention and the control groups (β = −0.025 [95% confidence interval {CI} = −0.198 to 0.147; P = 0.772]). In comparison with the control group, the DiabeText group showed significant ( P <0.05) improvements in self-reported medication adherence (odds ratio = 1.4; 95% CI = 1.0 to 1.9), DSES (Cohen’s d = 0.35), and EQ-5D-5L (Cohen’s d = 0.18) scores, but not for the rest of the secondary outcomes. Conclusion: DiabeText successfully improved quality of life, diabetes self-management, and self-reported medication adherence in primary care patients with T2DM. Further research is needed to enhance its effects on physiological outcomes.

AGAina M Galmes-Panades
Aina M Galmes-Panades
EAEscarlata Angullo-Martínez
Escarlata Angullo-Martínez
SMSofía Mira Martínez
Sofía Mira Martínez
Miquel Bennasar-VenyMiquel Bennasar-Veny
Miquel Bennasar-Veny
RCRocío Zamanillo Campos
Rocío Zamanillo Campos
IRIgnacio Ricci-Cabello
Ignacio Ricci-Cabello
Background: Type 2 diabetes mellitus (T2DM) is a highly prevalent disease associated with an increased risk of comorbidities, premature death, and health costs. Prediabetes is a stage of glucose alteration previous to T2DM, that can be reversed. The aim of the study is to develop and evaluate a low-intensity, multifaceted, digital intervention to prevent T2DM. The intervention comprises: (1) the use of mobile health technology to send tailored text messages promoting lifestyle changes to people at risk of T2DM and (2) the provision of online education to primary healthcare physicians and nurses about management of prediabetes. Methods: In stages 1–4 we will design, develop and pilot-test the intervention. In Stage 5 we will conduct a phase II, six-month, three-arm, cluster randomized, clinical trial with 42 primary care professionals and 420 patients at risk of T2DM. Patients will be allocated to a control group (usual care), intervention A (patient messaging intervention), or intervention B (patient messaging intervention plus online education to their primary healthcare professionals). The primary outcome will be glycated haemoglobin. All the procedures obtained ethical approval in June 2021 (CEI-IB Ref No: IB4495/21PI). Discussion: Digital health interventions can effectively prevent T2DM and reduce important T2DM risk factors such as overweight or hypertension. In Spain, this type of intervention is understudied. Moreover, there is controversy regarding the type of digital health interventions that are more effective. Findings from this study may contribute to address T2DM prevention, through a low-cost and easily implementable intervention.

9 October 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SMSofía Mira Martínez
Sofía Mira Martínez
NMNarges Malih
Narges Malih
EAESCARLATA ANGULLO
ESCARLATA ANGULLO
RCRocío Zamanillo Campos
Rocío Zamanillo Campos
Aina M YañezAina M Yañez
Aina M Yañez
IRIgnacio Ricci-Cabello
Ignacio Ricci-Cabello
Background: The diabetes epidemic continues to surge worldwide, demanding urgent and innovative solutions. Digital health interventions, particularly those targeting behavior change, hold promise due to their affordability and scalability. However, research in this field remains in its early stages. Objective: This study aimed to evaluate the effectiveness of PREDIABETEXT (Prediabetes Text Message Digital Intervention for the Prevention of Type 2 Diabetes Mellitus), a digital health intervention, in reducing glycated hemoglobin (HbA1c) and in improving secondary clinical, physiological, and behavioral outcomes. Methods: We conducted a 6-month, 3-arm, pragmatic cluster randomized clinical trial. We recruited patients with prediabetes (HbA1c levels between 6% and 6.4% in the previous 3 months or 2 consecutive fasting plasma glucose measurements of 110-125 mg/dL) registered at primary care centers in the Balearic Islands, Spain. The PREDIABETEXT intervention consisted of 3 personalized SMS text messages per week aimed at supporting lifestyle behavior changes and online training for their primary health care professionals. A total of 58 professionals (clusters) from 16 centers participated in the study and were randomized (1:1:1) to intervention group A (patient SMS text messaging), intervention group B (patient SMS text messaging+health care professional web-based training), or the control group (usual care). Following the 6-month intervention period, we conducted individual qualitative interviews with 8 patients and 7 health care professionals to evaluate their experiences with the intervention in terms of utility, satisfaction, and implementation barriers. Results: In total, 58 health care professionals (clusters) were included, allocated to the control group (n=20, 34%; 119/365, 32.6% patients), intervention group A (SMS text messaging only; n=18, 31%; 106/365, 29% patients), and intervention group B (SMS text messaging+training; n=20, 34%; 140/365, 38.4% patients). The mean age of the patients was 59.79 (SD 9.75) years, and 54.5% (199/365) were female. The results of the intention-to-treat analysis at the 6-month time point showed that intervention A led to a small, nonsignificant reduction in HbA1c levels compared to the control group (β=−0.05, 95% CI −0.21 to 0.10; P=.50), whereas intervention B showed a similar nonsignificant reduction (β=−0.04, 95% CI −0.12 to 0.10; P=.56). No substantial differences were observed in the remaining secondary outcomes. Interviews revealed positive feedback from patients, who appreciated the intervention’s dietary messages and their frequency and practicality. Participants suggested enhancements such as increased personalization, links to recipes, and nursing follow-ups. Health care professionals valued the online training but highlighted time constraints, suggesting shorter or blended formats to improve accessibility. Conclusions: While PREDIABETEXT did not significantly improve HbA1c levels, it demonstrated potential benefits for patient engagement. Further studies involving more intensive interventions are warranted to confirm the clinical impact on diabetes prevention. Trial Registration: ClinicalTrials.gov NCT05110625; https://www.clinicaltrials.gov/study/NCT05110625 International Registered Report Identifier (IRRID): RR2-10.3390/ijerph192214706

29 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
RCRocío Zamanillo Campos
Rocío Zamanillo Campos
MFMaria A Fiol-deRoque
Maria A Fiol-deRoque
MSMARIA J SERRANO-RIPOLL
MARIA J SERRANO-RIPOLL
JLJoan Llobera-Canaves
Joan Llobera-Canaves
JTJoana María Taltavull-Aparicio
Joana María Taltavull-Aparicio
IRIgnacio Ricci-Cabello
Ignacio Ricci-Cabello
Background Complications arising from uncontrolled Type 2 Diabetes (T2D) poses a significant burden on individuals’ well-being and healthcare resources. Digital interventions may play a key role in mitigating such complications by supporting patients to adequately self-manage their condition. Aim To assess the impact of DiabeText, a new theory-based, patient-centered, mobile health intervention integrated with electronic health records to send tailored short text messages to support T2D self-management. Design and setting Pragmatic, phase III, 12-month, two-arm randomized clinical trial with T2D primary care patients in Spain. Method 742 participants with suboptimal glycemic control (HbA1c>7.5) were randomly allocated to a control (usual care) or intervention (DiabeText) group. The DiabeText group received, in addition to usual care, 165 messages focused on healthy lifestyle and medication adherence. Primary outcome: glycated hemoglobin (HbA1c). Secondary outcomes: medication possession ratio, quality of life (EQ-5D-5L), diabetes self-efficacy (DSES); and self-reported adherence to medication, Mediterranean diet (MEDAS-14), and physical activity (IPAQ). Results At 12 months follow-up, no statistically significant differences in mean HbA1c were observed between the intervention (7.5 [95%CI 6.7 to 8.2]) and control groups (7.4 [6.7 to 8.3]). In comparison with the control group, the DiabeText group showed significant (p<0.05) improvements in self-reported medication adherence (OR=1.4; 95%CI: 1.0 to 1.9), DSES (Cohen’s d=0.4), and EQ5D-5L (Cohen’s d=0.2) scores; but not in the rest of secondary outcomes. Conclusion DiabeText successfully improved quality of life, diabetes self-management, and self-reported medication adherence in primary care patients with T2D. Further research is needed to enhance its effects on physiological outcomes.

7 January 2025 in JMIR Preprints
Verified
Preprint
Open access
SMSofía Mira Martínez
Sofía Mira Martínez
NMNarges Malih
Narges Malih
EAESCARLATA ANGULLO
ESCARLATA ANGULLO
RCRocío Zamanillo Campos
Rocío Zamanillo Campos
Aina M YañezAina M Yañez
Aina M Yañez
IRIgnacio Ricci-Cabello
Ignacio Ricci-Cabello
BACKGROUND The diabetes epidemic continues to surge worldwide, demanding urgent and innovative solutions. Digital health interventions, particularly those targeting behavior change, hold promise due to their affordability and scalability. However, research in this field remains in its early stages. OBJECTIVE This study aimed to evaluate the effectiveness of PREDIABETEXT (Prediabetes Text Message Digital Intervention for the Prevention of Type 2 Diabetes Mellitus), a digital health intervention, in reducing glycated hemoglobin (HbA1c) and in improving secondary clinical, physiological, and behavioral outcomes. METHODS We conducted a 6-month, 3-arm, pragmatic cluster randomized clinical trial. We recruited patients with prediabetes (HbA1c levels between 6% and 6.4% in the previous 3 months or 2 consecutive fasting plasma glucose measurements of 110-125 mg/dL) registered at primary care centers in the Balearic Islands, Spain. The PREDIABETEXT intervention consisted of 3 personalized SMS text messages per week aimed at supporting lifestyle behavior changes and online training for their primary health care professionals. A total of 58 professionals (clusters) from 16 centers participated in the study and were randomized (1:1:1) to intervention group A (patient SMS text messaging), intervention group B (patient SMS text messaging+health care professional web-based training), or the control group (usual care). Following the 6-month intervention period, we conducted individual qualitative interviews with 8 patients and 7 health care professionals to evaluate their experiences with the intervention in terms of utility, satisfaction, and implementation barriers. RESULTS In total, 58 health care professionals (clusters) were included, allocated to the control group (n=20, 34%; 119/365, 32.6% patients), intervention group A (SMS text messaging only; n=18, 31%; 106/365, 29% patients), and intervention group B (SMS text messaging+training; n=20, 34%; 140/365, 38.4% patients). The mean age of the patients was 59.79 (SD 9.75) years, and 54.5% (199/365) were female. The results of the intention-to-treat analysis at the 6-month time point showed that intervention A led to a small, nonsignificant reduction in HbA1c levels compared to the control group (β=−0.05, 95% CI −0.21 to 0.10; P=.50), whereas intervention B showed a similar nonsignificant reduction (β=−0.04, 95% CI −0.12 to 0.10; P=.56). No substantial differences were observed in the remaining secondary outcomes. Interviews revealed positive feedback from patients, who appreciated the intervention’s dietary messages and their frequency and practicality. Participants suggested enhancements such as increased personalization, links to recipes, and nursing follow-ups. Health care professionals valued the online training but highlighted time constraints, suggesting shorter or blended formats to improve accessibility. CONCLUSIONS While PREDIABETEXT did not significantly improve HbA1c levels, it demonstrated potential benefits for patient engagement. Further studies involving more intensive interventions are warranted to confirm the clinical impact on diabetes prevention. CLINICALTRIAL ClinicalTrials.gov NCT05110625; https://www.clinicaltrials.gov/study/NCT05110625 INTERNATIONAL REGISTERED REPORT RR2-10.3390/ijerph192214706

27 March 2022 in MetaArXiv
Verified
Preprint
Open access
SMSofía Mira Martínez
Sofía Mira Martínez
APAina Galmés Panades
Aina Galmés Panades
MVMiquel Bennasar Veny
Miquel Bennasar Veny
JKJadwiga Anna Konieczna
Jadwiga Anna Konieczna
RCRocío Zamanillo Campos
Rocío Zamanillo Campos
ICIgnacio Ricci Cabello
Ignacio Ricci Cabello
Type 2 diabetes mellitus (T2DM) based on: i) the use of a system comprising mobile health (mHealth) technology integrated with electronic health records to send tailored text messages (SMSs) promoting lifestyle changes in people at risk of T2DM, and, ii) the provision of online education to primary healthcare workers about prediabetes management. Design: The PREDIABETEXT project is a controlled, parallel, three-arm, cluster randomized trial and involve five phases. Methods: In phases 1-4 we will develop and pilot-test the different components of the intervention (In phase 1 we will develop the brief text messages targeted to patients; In phase 2 we will adapt our existing technology system to deliver the messages; In phase 3 we will develop an educational intervention targeted to Primary Care workers, and; In phase 4 we will pilot-test and optimise both interventions). In phase 5 we will conduct a phase II, six-month, three-arm, cluster randomised, clinical trial with 42 primary care workers and 420 patients at risk of T2DM (HbA1c from 6% to 6.4% or fasting plasma glucose 110-125mg/dl, or both). Patients will be allocated to a control (usual care) group, intervention A (patient messaging intervention), or intervention B (patient messaging intervention plus online education to their primary healthcare workers). The primary outcome will be HbA1c. Secondary outcomes will include additional clinical, physiological, behavioural and psychological outcomes. Discussion: Recent trials suggest that digital health interventions can effectively prevent T2DM and reduce important T2DM risk factors such as overweight or hypertension. In Spain this type of interventions is understudied.